CIM
TMDX icon

Contravisory Investment Management’s Transmedics TMDX Stock Holding History

Contravisory Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-212
Closed -$11.6K – 417
2023
Q3 		$11.6K Hold
212
– – ﹤0.01% 275
2023
Q2 		$17.8K Buy
+212
New +$16.2K ﹤0.01% 244

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Contravisory Investment Management's TMDX Position: Q4 2023 in Review

Contravisory Investment Management sold out of Transmedics (TMDX) in Q4 2023, closing a stake of 212 shares — an estimated $11.6K sold.

Contravisory Investment Management first reported a position in TMDX in Q2 2023 and held it in 2 quarters. The position peaked at $17.8K in Q2 2023. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

  • Contravisory Investment Management reported no remaining Transmedics position as of Q4 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 212 Transmedics shares in Q4 2023, an estimated $11.6K.
  • Contravisory Investment Management first reported a position in Transmedics in Q2 2023 and held it in 2 quarters.
  • Contravisory Investment Management's Transmedics position peaked at $17.8K in Q2 2023.
  • 248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on Contravisory Investment Management's 13F filing for Q4 2023, filed 11 Jan 2024.